Phio Pharmaceuticals

Phio Pharmaceuticals Corp. is a biotechnology company developing next-generation immuno-oncology therapies based on its self-delivering RNAi (INTASYL™) therapeutic platform. Phio Pharmaceuticals is committed to developing innovative cancer treatments that overcome tumor immune suppression and weaponize the immune system to fight cancer without genetic modification.